Labeled monocyte infiltration techniques have been used to study delayed-type hypersensitivity responses in mice immunized with St. Louis encephalitis virus. A delayed 24-to 48-h inflammatory response occurred 6 to 7 days after immunization. This response can be potentiated by cyclophosphamide treatment, by BCG administration, or by splenectomy. Treatments known to selectivity inhibit T-cell function suppressed the response.
The development of central nervous system lesions after St. Louis encephalitis (SLE) virus infection has long been associated with cellular infiltrates and inflammatory responses (18) . Recent investigations have demonstrated that thymus-dependent cell (T-cell)-mediated responses play both protective and immunopathological roles in mice infected with a number of flaviviruses related to SLE (1, 9, 12, 15) . In perhaps the best-studied model of virus disease in mice, lymphocytic choriomeningitis, the development of T-cell-mediated central nervous system disease is clearly associated with the development of peripheral footpad inflammatory responses (5) . Peripheral delayed inflammatory responses in mice immunized against other viruses, however, are typically slight and difficult to evaluate quantitatively (4) . In studies of cell-mediated response to viruses other than lymphocytic choriomeningitis and ectromelia (16) , migration inhibition tests (12) or cytotoxic cell assays have usually been used (7) . Direct T-cell-mediated cytotoxicity is relatively inefficient in controlling flavivirus replication in vitro (2, 7) . It seems likely, therefore, that in vivo studies of the delayed inflammatory response might be useful in evaluating the immune response to flavivirus infection. We have investigated the use of labeled monocyte infiltration techniques (6, 10) for measurement of the delayed-type hypersensitivity (DTH) response in mice infected with SLE virus.
MATERIALS AND METHODS
Virus stock and control inoculum. SLE virus strain BeH 203235 was obtained from Robert Shope, Yale Arbovirus Research Unit, Yale University, New Haven, Conn. Stock virus was prepared as a 10% (wt/ vol) suspension of infected suckling mouse brain in phosphate-buffered saline containing 5% bovine serum albumin (BAPS). Virus infectivity titers were determined by plaque formation on CER cells (13) . The working stock virus preparation had a titer of 3.2 x 108 plaque-forming units (PFU) per ml. A suspension of normal suckling mouse brain (NSMB) was prepared by the same methods as those used for preparation of virus-infected suckling mouse brain.
Mice. All mice used in this work were reared at our facility and were produced from stocks of National Institutes of Health general purpose albino mice. Mice were free of intercurrent infections with mouse pathogens with the exception of periodic problems caused by infection with Tyzzer's bacillus (Bacillus piliformis). All mice were weaned at 3 weeks of age, and the females were pooled, caged, and held for 4 humoral antibody and peripheral delayed inflammatory responses were studied.
Delayed 24-h footpad swelling and cellular infiltration during the 12 days after infection. Mice were infected by intraperitoneal inoculation with 1,000 PFU of SLE virus. Control mice received equivalent inoculations of NSMB suspension. The level of the delayed 24-h inflammatory response was measured at intervals after infection (p.i.). At each interval the footpads of groups of eight mice were challenged. Differential footpad swelling and cellular infiltration were assessed 24 h later. Figure 1 presents the results obtained. Differential footpad swelling reached the highest levels on day 6 p.i. and decreased rapidly to negligible levels by day 10. Labeled CIR reached statistically significant levels on days 6 to 8, after which they declined rapidly, reaching normal control levels by day 10.
Time courses of inflammation and labeled cell infiltration. The time courses of inflammation and cellular infiltration were measured in mice infected as in the previous section and challenged 6 days p.i. The responses of groups of five immunized and five control mice were measured at intervals up to 72 h after footpad challenge. Figure 2 shows the development of the responses. All mice challenged with mouse brain suspensions exhibited a prominent nonspecific inflammatory response within minutes of footpad inoculation. Residual footpad swelling from this response was still measurable 2 to 4 h after inoculation. The swelling continued to decrease in control mice and was essentially undetectable 24 and 48 h after footpad challenge. A moderate inflammatory response was detect- able in the SLE virus-infected mice. This response was highest 24 h after footpad challenge and, although significantly different from control values, did not exceed 0.25 mm. Labeled cellular infiltration in infected mice was not evident at 24 h after footpad challenge, was noticeable at 9 h after challenge, and was significantly different from that in control mice at 24 h (a < 0.01).
Character of the cellular infiltrate. Histological examination of the footpads 24 h after challenge revealed a certain amount of inoculation trauma and accompanying polymorphonuclear cell infiltration in both feet of control animals. In the SLE virus-infected mice, however, cellular infiltration in the virus-challenged feet was three to four times that observed in the feet from control animals. The At the time of SLE infection, all groups of mice were separated into five equal portions and inoculated intravenously with SLE (6.5 x 101, 6 .5 x 103, 6 .5 x 105, 6 .5 x 107 PFU) and with a normal suckling mouse brain dilution equivalent to the highest SLE virus dose. Eight of the normal, PHA-cyclophosphamide-, BCG-, and cyclophosphamide-treated mice and five of the splenectomized and sham-splenectomized mice of each treatment group were challenged in the footpads at intervals for 10 days p.i. The CIR were measured 24 h later. No appreciable response was noted in any of the control groups inoculated with normal suckling mouse brain suspensions. All responding groups of SLE-infected mice, regardless of the infecting dose of SLE virus administered, yielded maximum or near maximum 24-h CIR at 5 to 6 days after infection. Normal mice, sham-splenectomized VOL. 24, 1979 on October 26, 2017 by guest http://iai.asm.org/ Downloaded from mice, mice treated with BCG, and mice given cyclophosphamide 2 days before SLE infection all showed a consistent SLE dose-related increase in cellular infiltration but were not significantly different from each other on day 6 p.i. Figure 3 shows the effects of SLE virus-infecting dose on the 24-h response to footpad challenge given on day 6 p.i. For simplicity of presentation, data for the normal SLE-infected mice have been excluded from the figure. Mice treated with PHA plus cyclophosphamide showed no evidence of significant labeled cell infiltration. A marked dose-dependent enhancement of the response was evident in splenectomized animals, with optimally enhanced responses being obtained with the dose of 6.5 x 105 PFU of SLE virus.
Although neither BCG nor cyclophosphamide given before infection amplified the response at 6 days p.i., both treatments prolonged the response. This is shown in Fig. 4 which presents the development of the footpad cellular infiltration response from days 3 to 10 p.i. with 6. PHA plus cyclophosphamide caused almost complete suppression of the 24-h response.
The data presented in Fig. 3 and 4 suggest that the 24-h labeled cellular infiltration may be T-cell mediated. Thus, the treatments known to potentiate DTH also potentiate or prolong the 24-h cellular infiltration responses, and the treatment known to suppress T-cell responses causes virtual elimination of 24-h cellular infiltration. A remaining reservation was caused by the lack of available knowledge pertaining to the effects of the immunoregulatory treatments on antibody responses to SLE virus. These effects were therefore measured. Six groups of mice were prepared. These (6, 10) , revealed a time course characteristic of delayed responses. Immunomodifications such as splenectomy, cyclophosphamide treatment, and BCG administration, which are known to potentiate T-cell-mediated peripheral DTH responses (16) , either potentiated or prolonged the delayed 24-h response in mice. Treatment with PHA plus cyclophosphamide, a procedure developed to suppress splenic T-helper-cell responses (11) , suppressed the footpad inflammatory response. The degree of inflammation appeared to be independent of the antibody response. PHA-cyclophosphamide treatment, which suppressed the footpad response, did not alter the antibody response. Either splenectomy or cyclophosphamide treatment given 2 days before SLE infection enhanced the footpad responses but reduced the level of antibody produced at 6 to 8 days.
The footpad response after SLE infection, therefore, meets most of the criteria of the typical transitory peripheral DTH responses shown to occur after stimulation of mice with nonreplicating antigens (3, 8) . The T-cell-mediated response, assessed by cytotoxicity assays or by splenocyte migration indexes, has been shown to play both protective and immunopathological roles in mice infected with a number of related flaviviruses (1, 4, 5, 12) . Differentiation of the relative contributions of cell-mediated and humoral factors to immunity has been difficult, however, since the assessment of protection has usually depended on intracerebral inoculation of the virus into immunized animals which exhibit both cellular and humoral immunity. Since both peripheral delayed inflammatory responses and humoral antibody levels can be easily manipulated by established immunoregulatory techniques, it should be possible to assess the differential role of humoral and cell-mediated immunity in the development of resistance to SLE virus infection.
